Literature DB >> 2548167

Conservation of the secondary structure elements of the 5'-untranslated region of cardio- and aphthovirus RNAs.

E V Pilipenko1, V M Blinov, B K Chernov, T M Dmitrieva, V I Agol.   

Abstract

An analysis of published nucleotide sequences of the 5'-untranslated region (5'-UTR) of 7 cardioviruses and 3 aphthoviruses has allowed us to derive a consensus secondary structure model that differs from that previously proposed for the 5'-UTR of entero- and rhinoviruses, though all these viruses belong to the same family, Picornaviridae. The theoretical model derived here was experimentally supported by investigating the accessibility of encephalomyocarditis virus RNA to modifications with dimethyl sulfate and its susceptibility to S1 and cobra venom nucleases. The possible involvement of the 5"-UTR secondary structure domains in the translational control is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548167      PMCID: PMC318190          DOI: 10.1093/nar/17.14.5701

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus.

Authors:  B E Clarke; A L Brown; K M Currey; S E Newton; D J Rowlands; A R Carroll
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

Review 2.  The attenuation of poliovirus neurovirulence.

Authors:  J W Almond
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

3.  [Comparison of the secondary structure of 5'-terminal nontranslated segment of RNA from neurovirulent and attenuated strains of poliovirus].

Authors:  V M Blinov; E V Pilipenko; L I Romanova; A N Siniakov; S V Maslova
Journal:  Dokl Akad Nauk SSSR       Date:  1988

4.  A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.

Authors:  S K Jang; H G Kräusslich; M J Nicklin; G M Duke; A C Palmenberg; E Wimmer
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

5.  An RNA sequence of hundreds of nucleotides at the 5' end of poliovirus RNA is involved in allowing viral protein synthesis.

Authors:  D Trono; R Andino; D Baltimore
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

6.  Comparative sequence analysis of the 5' noncoding region of the enteroviruses and rhinoviruses.

Authors:  V M Rivera; J D Welsh; J V Maizel
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

7.  An internal 5'-noncoding region required for translation of poliovirus RNA in vitro.

Authors:  K Bienkowska-Szewczyk; E Ehrenfeld
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Translational efficiency of poliovirus mRNA: mapping inhibitory cis-acting elements within the 5' noncoding region.

Authors:  J Pelletier; G Kaplan; V R Racaniello; N Sonenberg
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

9.  Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region.

Authors:  J Pelletier; G Kaplan; V R Racaniello; N Sonenberg
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

10.  Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains.

Authors:  D C Pevear; J Borkowski; M Calenoff; C K Oh; B Ostrowski; H L Lipton
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

View more
  99 in total

1.  Distinct attenuation phenotypes caused by mutations in the translational starting window of Theiler's murine encephalomyelitis virus.

Authors:  E V Pilipenko; E G Viktorova; E V Khitrina; S V Maslova; N Jarousse; M Brahic; V I Agol
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Cross-talk between orientation-dependent recognition determinants of a complex control RNA element, the enterovirus oriR.

Authors:  W J Melchers; J M Bakkers; H J Bruins Slot; J M Galama; V I Agol; E V Pilipenko
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

3.  Cell-specific proteins regulate viral RNA translation and virus-induced disease.

Authors:  E V Pilipenko; E G Viktorova; S T Guest; V I Agol; R P Roos
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

4.  Conserved RNA secondary structures in Picornaviridae genomes.

Authors:  C Witwer; S Rauscher; I L Hofacker; P F Stadler
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

5.  A cell cycle-dependent protein serves as a template-specific translation initiation factor.

Authors:  E V Pilipenko; T V Pestova; V G Kolupaeva; E V Khitrina; A N Poperechnaya; V I Agol; C U Hellen
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

6.  Internal ribosomal entry site-mediated translation initiation in equine rhinitis A virus: similarities to and differences from that of foot-and-mouth disease virus.

Authors:  T M Hinton; F Li; B S Crabb
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Cap-independent translation by the 5' untranslated region of Theiler's murine encephalomyelitis virus.

Authors:  P K Bandyopadhyay; C Wang; H L Lipton
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures.

Authors:  E V Pilipenko; S V Maslova; A N Sinyakov; V I Agol
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

9.  Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5' noncoding region.

Authors:  J R Gebhard; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Cell proteins bind to a linear polypyrimidine-rich sequence within the 5'-untranslated region of rhinovirus 14 RNA.

Authors:  I A Rojas-Eisenring; M Cajero-Juarez; R M del Angel
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.